Minerva Neurosciences | NERV - Ebitda





Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Adma Biologics USD 55.44M 5.62M 2026-06
ALKERMES USD 120.06M 19.15M 2026-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
AstraZeneca USD 7.46B 2.3B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Cipla INR 13.88B 154.2M 2026-09
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 9.46B 3.54B 2026-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.99B 721M 2026-06
Merck USD 1.42B 2.97B 2026-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.36B 350M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12